Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Current Opinion in Immunology|January 29, 2019
Affinity war: forging immunoglobulin repertoiresTeng Zuo, Avneesh Gautam, Duane R Wesemann
Medical Oncology (Northwood, London, England)|May 13, 2011
Tetramethylpyrazine reverses multidrug resistance in breast cancer cells through regulating the expression and function of P-glycoproteinYinxu Zhang, Xiaomei Liu, Teng Zuo, et al.
Oncology Letters|March 22, 2016
Expression of cluster of differentiation 74 in gallbladder carcinoma and the correlation with epithelial growth factor receptor levelsPeng Wang, Qiao Shi, Teng Zuo, et al.
Journal of Virology|December 28, 2012
Unraveling of a neutralization mechanism by two human antibodies against conserved epitopes in the globular head of H5 hemagglutininMengran Qian, Hongxing Hu, Teng Zuo, et al.
Fish Physiology and Biochemistry|January 31, 2020
Cloning of hepatic lipase and the effects of dietary nutrition on hepatic lipase expression in genetically improved farmed tilapia (Oreochromis niloticus)Ting Liu, Kai Huang, Yimin Zheng, et al.
Social Science & Medicine (1982)|April 10, 2025
Communication analysis of the COVID-19 infodemic by medical practitioners in China: A mixed methods studyTeng Zuo, Lingfeng He, Yuan Zheng, et al.
The American Journal of Chinese Medicine|February 27, 2016
Role of Daphnetin in Rat Severe Acute Pancreatitis Through the Regulation of TLR4/NF-[Formula: see text]B Signaling Pathway ActivationZhiyong Liu, Jiao Liu, Kailiang Zhao, et al.
Frontiers in Aging|June 17, 2026
Gut microbiota-epigenetic interactions in systemic aging: mechanistic drivers for endocrine and reproductive network remodeling and therapeutic modulationChristopher Birigwa, Qiang Tong, Bing Qu, et al.
Foods (Basel, Switzerland)|November 13, 2025
Expression, Purification, and Functional Exploration of an α-Galactosidase from <i>Akkermansia muciniphila</i>Teng Zuo, Ziqian Yin, Zhiguo Li, et al.
Plos Pathogens|December 4, 2023
Breakthrough infection elicits hypermutated IGHV3-53/3-66 public antibodies with broad and potent neutralizing activity against SARS-CoV-2 variants including the emerging EG.5 lineagesLing Li, Xixian Chen, Zuowei Wang, et al.
Pageof 7